LambdaVision secures funding re artificial retina
LambdaVision has been selected by NASA for a Small Business Innovation Research (SBIR) Phase II award, worth $750,000 over two years. With the continued support...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
LambdaVision has been selected by NASA for a Small Business Innovation Research (SBIR) Phase II award, worth $750,000 over two years. With the continued support...
InveniAI® LLC has formed a strategic partnership with TB Alliance, a non-profit organization dedicated to the discovery, development, and delivery of better, faster-acting and affordable...
Architectural Building Systems is a multi-generational General Contracting and Construction Management firm that was founded in 1985 to serve the ever-changing needs of customers in...
Plans for a new 10-story, 500,000-square-foot bioscience building in downtown New Haven to feature lab, research, and incubator space have garnered a key approval. The...
Tangen Biosciences and LabWare have agreed to enter into an exclusive partnership whereby LabWare will distribute Tangen’s GeneSpark™ device as part of the LabWare’s Portable Disease...
The Hartford Business Journal has produced a special online publication, Leadership in a Time of Crisis: Letters of inspiration and hope from the stae’s business...
New England Cell Therapeutics was founded in 2019 with a mission to deliver cell therapy to patients suffering from a broad range of injuries and illnesses....
Azitra reports that the FDA has granted Rare Pediatric Disease Designation to ATR-12 for the treatment of Netherton syndrome (NS), a chronic genetic skin disease...
Sema4 has appointed prominent Wall Street and technology executive R. Martin Chavez to its Board of Directors. Mr. Chavez most recently served in several senior roles...
Cybrexa Therapeutics reports that two posters featuring Cybrexa’s pipeline will be presented at the American Association for Cancer Research Virtual Annual Meeting II, which will...